Complementary and alternative medicine use in patients with haematological malignancies in Europe
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Molassiotis, AlexanderMargulies, Anita
Fernandez-Ortega, Paz
Pud, Dorit
Panteli, Vassiliki
Bruyns, Ingrid
Scott, Julia A
Gudmundsdottir, Gudbjorg
Browall, Maria
Madsen, Elin
Ozden, Gulten
Magri, Miriam
Selvekerova, Sarka
Platin, Nurgun
Kearney, Nora
Patiraki, Elisabeth
Issue Date
2005-05-01
Metadata
Show full item recordCitation
Complement Ther Clin Pract 2005, 11(2):105-10Abstract
This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional well-being. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Link fieldae974a485f413a2113503eed53cd6c53
10.1016/j.ctcp.2004.12.005
Scopus Count
Collections
Related articles
- Complementary and alternative medicine use in lung cancer patients in eight European countries.
- Authors: Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E, Browall M, Fernandez-Ortega P, Pud D, Margulies A
- Issue date: 2006 Feb
- Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
- Authors: Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Platin N, Hummerston S, Scott JA, Panteli V, Gudmundsdottir G, Selvekerova S, Patiraki E, Kearney N
- Issue date: 2005 Dec
- Complementary and alternative medicine use in patients with head and neck cancers in Europe.
- Authors: Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, Milovics L, Panteli V, Gudmundsdottir G, Browall M, Madsen E, Patiraki E, Kearney N
- Issue date: 2006 Mar
- Use of complementary and alternative medicine among cancer patients in Israel.
- Authors: Pud D, Kaner E, Morag A, Ben-Ami S, Yaffe A
- Issue date: 2005 Jun
- Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
- Authors: Can G, Erol O, Aydiner A, Topuz E
- Issue date: 2009 Sep